Cyclooxygenase inhibitors decrease apoptosis initiated by actinomycin D, cycloheximide, and staurosporine in...

Area of Science:

• Cell Biology
• Biochemistry

Background:

• Apoptosis, or programmed cell death, is crucial for development and tissue homeostasis.
• Apoptotic cells have been observed in the amnion membrane, hinting at a role in membrane rupture.
• The molecular mechanisms regulating amnion cell apoptosis remain largely unknown.

Purpose of the Study:

• To investigate the role of cyclooxygenase (COX) and prostaglandins in amnion cell apoptosis.
• To determine if COX and prostaglandins are integral to apoptosis in amnion cells, similar to their roles in intestinal and renal cells.

Main Methods:

• Amnion-derived WISH cells were treated with apoptosis-inducing agents (actinomycin D, cycloheximide, staurosporine).
• Apoptosis was assessed using cell viability assays, DNA fragmentation analysis, and fluorescent in situ fragmentation analysis.
• Prostaglandin E2 (PGE2) output was measured, and the effects of COX inhibitors (indomethacin, piroxicam) were evaluated.

Main Results:

• WISH cells exhibited dose- and time-dependent apoptosis upon treatment with apoptosis-inducing agents.
• Treatment with these agents increased PGE2 production.
• Co-incubation with COX inhibitors significantly reduced both PGE2 levels and apoptosis.
• Specific data showed a marked decrease in apoptosis when COX inhibitors were used alongside actinomycin D.

Conclusions:

• Cyclooxygenase and prostaglandins play a significant role in regulating programmed cell death in cultured amnion cells.
• These findings suggest a potential mechanism for amnion membrane rupture involving COX and prostaglandin pathways.